SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Appropriations | ₹105 Cr | ₹79 Cr | ₹62 Cr | ₹1,709,353 Cr | ₹17 Cr |
What is the latest Appropriations of SYNCOM FORMULATIONS (INDIA) ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹105 Cr |
| Mar2024 | ₹79 Cr |
| Mar2023 | ₹62 Cr |
| Mar2022 | ₹1,709,353 Cr |
| Mar2017 | ₹17 Cr |
How is Appropriations of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹105 Cr | 31.90 | |
| Mar2024 | ₹79 Cr | 27.77 | |
| Mar2023 | ₹62 Cr | -100.00 | |
| Mar2022 | ₹1,709,353 Cr | 9,801,799.59 | |
| Mar2017 | ₹17 Cr | - | |
Compare Appropriations of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,128.0 Cr | -5.2% | -19.3% | -35.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -5.2% |
-19.3% |
-35.4% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses